Answers are grounded in this paper and cite their sources.
Lysosomal Storage Diseases are multisystemic disorders determined by genetic variants, which affect the proteins involved in lysosomal function and cellular metabolism. Different therapeutic approaches, which are based on the physiologic mechanisms that regulate lysosomal function, have been proposed for these diseases. Currently, enzyme replacement therapy, gene therapy, or small molecules have been approved or are under clinical development to treat lysosomal storage disorders. The present article reviews the main therapeutic strategies that have been proposed so far, highlighting possible limitations and future perspectives.
No takes yet. Share an insight, caveat, or question.
Fernández-Pereira et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: